Molecular genetics of human intracranial aneurysms

International Journal of Stroke

Volumn 3, Issue 4, 2008, Pages 272-287

  Zhang, Jun ^a   Claterbuck, Richard E ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Genetics; Intracranial aneurysms; Linkage

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LIPOPROTEIN;

ANEURYSM RUPTURE; CONNECTIVE TISSUE; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEMODYNAMIC STRESS; HEREDITY; HUMAN; HUMAN GENOME; INTRACRANIAL ANEURYSM; LIPOPROTEIN METABOLISM; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL ANEURYSM; MOLECULAR BIOLOGY;

EID: 52249104718     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2008.00224.x     Document Type: Review

References (231)

1. Rinkel GJ, Djibuti M, Algra A, van Gijn J: Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke 1998; 29:251-6.
2. King JT Jr: Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimag Clin N Am 1997; 7:659-68.
3. Huang TY, Lin CL, Chang CZ, Howng SL: Familial intracranial aneurysms. Kaohsiung J Med Sci 1998; 14:242-6.
4. Lasjaunias P, Porter P: Molecular anatomy of an intracranial aneurysm. Stroke 2001; 32:2725-6.
5. Lasjaunias P, Wuppalapati S, Alvarez H, Rodesch G, Ozanne A: Intracranial aneurysms in children aged under 15 years: Review of 59 consecutive children with 75 aneurysms. Childs Nerv Syst 2005; 21:437-50.
6. Becker KJ: Epidemiology and clinical presentation of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 1998; 9:435-44.
7. Feldmann E, Broderick JP, Kernan WN et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005; 36:1881-5.
8. Longstreth WT Jr, Nelson LM: Smoking cessation and risk of stroke in women. JAMA 1993; 269:2214.
9. Connolly ES Jr, Choudhri TF, Mack WJ et al. Influence of smoking, hypertension, and sex on the phenotypic expression of familial intracranial aneurysms in siblings. Neurosurgery 2001; 48:64-8; discussion 68-9.
10. Teunissen LL, Rinkel GJ, Algra A, van Gijn J: Risk factors for subarachnoid hemorrhage: A systematic review. Stroke 1996; 27:544-9.
11. Kissela BM, Sauerbeck L, Woo D et al. Subarachnoid hemorrhage: A preventable disease with a heritable component. Stroke 2002; 33:1321-6.
12. Herzig R, Urbanek K, Vlachova I et al. The role of chronic alcohol intake in patients with spontaneous intracranial hemorrhage: A carbohydrate-deficient transferrin study. Cerebrovasc Dis 2003; 15:22-8.
13. Pleizier CM, Ruigrok YM, Rinkel GJ: Relation between age and number of aneurysms in patients with subarachnoid haemorrhage. Cerebrovasc Dis 2002; 14:51-3.
14. Leblanc R: Familial cerebral aneurysms. A bias for women. Stroke 1996; 27:1050-4.
15. Struycken PM, Pals G, Limburg M et al. Anticipation in familial intracranial aneurysms in consecutive generations. Eur J Hum Genet 2003; 11:737-43.
16. Stehbens WE: Hypertension and cerebral aneurysms. Med J Aust 1962; 49:8-10.
17. Kaku DA, Lowenstein DH: Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 1990; 113:821-7.
18. Nanda A, Vannemreddy PS, Polin RS, Willis BK: Intracranial aneurysms and cocaine abuse: Analysis of prognostic indicators. Neurosurgery 2000; 46:1063-7; discussion 1067-9.
19. Howington JU, Kutz SC, Wilding GE, Awasthi D: Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 99:271-5.
20. Juvela S, Porras M, Poussa K: Natural history of unruptured intracranial aneurysms: Probability and risk factors for aneurysm rupture. J Neurosurg 2000; 93:379-87.
21. Ellamushi HE, Grieve JP, Jager HR, Kitchen ND: Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg 2001; 94:728-32.
22. Krex D, Schackert HK, Schackert G: Genesis of cerebral aneurysms - an update. Acta Neurochir (Wien) 2001; 143:429-48; discussion 448-29.
23. Juvela S: Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol 1996; 53:734-40.
24. Juvela S, Poussa K, Porras M: Factors affecting formation and growth of intracranial aneurysms: A long-term follow-up study. Stroke 2001; 32:485-91.
25. Isaksen J, Egge A, Waterloo K, Romner B, Ingebrigtsen T: Risk factors for aneurysmal subarachnoid haemorrhage: The Tromso study. J Neurol Neurosurg Psychiatry 2002; 73:185-7.
26. Inagawa T: Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan. J Neurosurg 2005; 102:60-7.
27. Horikoshi T, Akiyama I, Yamagata Z, Sugita M, Nukui H: Magnetic resonance angiographic evidence of sex-linked variations in the circle of willis and the occurrence of cerebral aneurysms. J Neurosurg 2002; 96:697-703.
28. Dennis GC, Welch B, Cole AN et al. Subarachnoid hemorrhage in the African-American population: A cooperative study. J Natl Med Assoc 1997; 89:101-8.
29. Gu YX, Chen XC, Song DL, Leng B, Zhao F: Risk factors for intracranial aneurysm in a Chinese ethnic population. Chin Med J (England) 2006; 119:1359-64.
30. Ohaegbulam SC, Dujovny M, Ausman JI, Diaz FG, Malik GM: Ethnic distribution of intracranial aneurysms. Acta Neurochir (Wien) 1990; 106:132-5.
31. Kim DH, Van Ginhoven G, Milewicz DM: Incidence of familial intracranial aneurysms in 200 patients: Comparison among Caucasian, African-American, and Hispanic populations. Neurosurgery 2003; 53:302-8.
32. Acosta-Rua GJ: Familial incidence of ruptured intracranial aneurysms. Report of 12 cases. Arch Neurol 1978; 35:675-7.
33. Lozano AM, Leblanc R: Familial intracranial aneurysms. J Neurosurg 1987; 66:522-8.
34. Norrgard O, Angquist KA, Fodstad H, Forsell A, Lindberg M: Intracranial aneurysms and heredity. Neurosurgery 1987; 20:236-9.
35. ter Berg HW, Dippel DW, Limburg M, Schievink WI, van Gijn J: Familial intracranial aneurysms. A review. Stroke 1992; 23:1024-30.
36. Sharma RR, Cast IP: Cerebral berry aneurysms in identical twins. Surg Neurol 1993; 40:349-50.
37. Alberts MJ, Quinones A, Graffagnino C, Friedman A, Roses AD: Risk of intracranial aneurysms in families with subarachnoid hemorrhage. Can J Neurol Sci 1995; 22:121-5.
38. De Braekeleer M, Perusse L, Cantin L, Bouchard JM, Mathieu J: A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet 1996; 60:99-104.
39. Mathieu J, Perusse L, Allard P et al. Epidemiological study of ruptured intracranial aneurysms in the Saguenay-Lac-Saint-Jean region (Quebec, Canada). Can J Neurol Sci 1996; 23:184-8.
40. Mathieu J, Hebert G, Perusse L et al. Familial intracranial aneurysms: recurrence risk and accidental aggregation study. Can J Neurol Sci 1997; 24:326-31.
41. Leblanc R: Familial cerebral aneurysms. Can J Neurol Sci 1997; 24:191-9.
42. Ronkainen A, Hernesniemi J, Puranen M et al. Familial intracranial aneurysms. Lancet 1997; 349:380-4.
43. Schievink WI: Genetics of intracranial aneurysms. Neurosurgery 1997; 40:651-62.
44. Schievink WI: Genetics and aneurysm formation. Neurosurg Clin N Am 1998; 9:485-95.
45. Pfohman M, Criddle LM: Epidemiology of intracranial aneurysm and subarachnoid hemorrhage. J Neurosci Nurs 2001; 33:39-41.
46. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG: A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 2003; 99:637-43.
47. Okamoto K, Horisawa R, Kawamura T et al. Family history and risk of subarachnoid hemorrhage: A case-control study in Nagoya, Japan. Stroke 2003; 34:422-6.
48. Ohno S, Ikeda Y, Onitsuka T et al. [Cerebral aneurysms in identical twins]. No Shinkei Geka 2004; 32:875-9.
49. Sharma P, Brown MJ: Neurovascular lessons from a pair of identical twins with cerebral aneurysms. Postgrad Med J 2001; 77:197-8.
50. Sakovich VP, Lebedeva ER, Nalesnik MV: Heredity in intracranial aneurysms (a study of identical twins). Zh Vopr Neirokhir Im N N Burdenko 1998; 33-5.
51. Vega-Basulto SD, Montejo-Montejo J, Silva-AdAn S, Mosqueda-Betancourt G: Familial intracranial aneurysms in Camaguey. Rev Neurol 2003; 36:218-23.
52. Broderick JP, Sauerbeck LR, Foroud T et al. The familial intracranial aneurysm (FIA) study protocol. BMC Med Genet 2005; 6:17.
53. Ruigrok YM, Rinkel GJ, Wijmenga C: Genetics of intracranial aneurysms. Lancet Neurol 2005; 4:179-89.
54. Krischek B, Inoue I: The genetics of intracranial aneurysms. J Hum Genet 2006; 51:587-94.
55. Miyazawa N, Akiyama I, Yamagata Z: Risk factors for growth of unruptured intracranial aneurysms: Follow-up study by serial 0.5-T magnetic resonance angiography. Neurosurgery 2006; 58:1047-53.
56. Lindgaard L, Eskesen V, Gjerris F, Olsen NV: Familial aggregation of intracranial aneurysms in an Inuit patient population in Kalaallit Nunaat (Greenland). Neurosurgery 2003; 52:357-62.
57. Krischek B, Narita A, Akagawa H et al. Is there any evidence for linkage on chromosome 17cen in affected Japanese sib-pairs with an intracranial aneurysm? J Hum Genet 2006; 51:491-4.
58. Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN: Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003; 35:1341-60.
59. Salkowski A, Tromp G, Greb A, Womble D, Kuivaniemi H: Web-site-based recruitment for research studies on abdominal aortic and intracranial aneurysms. Genet Test 2001; 5:307-10.
60. Ruigrok YM, Rinkel GJ, Wijmenga C, Van Gijn J: Anticipation and phenotype in familial intracranial aneurysms. J Neurol Neurosurg Psychiatry 2004; 75:1436-42.
61. Wang MC, Rubinstein D, Kindt GW, Breeze RE: Prevalence of intracranial aneurysms in first-degree relatives of patients with aneurysms. Neurosurg Focus 2002; 13:e2.
62. Wills S, Ronkainen A, van der Voet M et al. Familial intracranial aneurysms: An analysis of 346 multiplex Finnish families. Stroke 2003; 34:1370-4.
63. Kirkpatrick PJ, McConnell RS: Screening for familial intracranial aneurysms. BMJ 1999; 319:1512-3.
64. Ruigrok YM, Rinkel GJ, Wijmenga C: Familial intracranial aneurysms. Stroke 2004; 35: E59-60; author reply e59-60.
65. Vega C, Kwoon JV, Cavine SD: Intracranial aneurysms: current evidence and clinical practice. Am Fam Physician 2002; 66:601-8.
66. ter Berg HW, Bijlsma JB, Veiga Pires JA et al. Familial association of intracranial aneurysms and multiple congenital anomalies. Arch Neurol 1986; 43:30-3.
67. Arteaga-Solis E, Gayraud B, Ramirez F: Elastic and collagenous networks in vascular diseases. Cell Struct Funct 2000; 25:69-72.
68. Nekrysh SY: Association between heritable connective tissue disorders and intracranial aneurysms. Surg Neurol 2000; 54:77-8.
69. Belz MM, Fick-Brosnahan GM, Hughes RL et al. Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 2003; 63:1824-30.
70. Watnick T, Phakdeekitcharoen B, Johnson A et al. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet 1999; 65:1561-71.
71. van den Berg JS, Limburg M, Pals G, Arwert F, Westerveld A: Type III collagen deficiency in a family with intracranial aneurysms. Cerebrovasc Dis 2001; 11:92-4.
72. Grond-Ginsbach C, Schnippering H, Hausser I et al. Ultrastructural connective tissue aberrations in patients with intracranial aneurysms. Stroke 2002; 33:2192-6.
73. Higashida RT, Halbach VV, Hieshima GB, Cahan L: Cavernous carotid artery aneurysm associated with Marfan's syndrome: Treatment by balloon embolization therapy. Neurosurgery 1988; 22:297-300.
74. Matsuda M, Matsuda I, Handa H, Okamoto K: Intracavernous giant aneurysm associated with Marfan's syndrome. Surg Neurol 1979; 12:119-21.
75. Schievink WI: Marfan syndrome and intracranial aneurysms. Stroke 1999; 30:2767-8.
76. Schievink WI, Parisi JE, Piepgras DG, Michels VV: Intracranial aneurysms in Marfan's syndrome: An autopsy study. Neurosurgery 1997; 41:866-70; discussion 871.
77. Munyer TP, Margulis AR: Pseudoxanthoma elasticum with internal carotid artery aneurysm. Am J Roentgenol 1981; 136:1023-4.
78. van den Berg JS, Hennekam RC, Cruysberg JR et al. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in Pseudoxanthoma elasticum. Cerebrovasc Dis 2000; 10:315-9.
79. Chapman AB, Rubinstein D, Hughes R et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327:916-20.
80. Fehlings MG, Gentili F: The association between polycystic kidney disease and cerebral aneurysms. Can J Neurol Sci 1991; 18:505-9.
81. van den Berg JS, Limburg M, Hennekam RC: Is Marfan syndrome associated with symptomatic intracranial aneurysms? Stroke 1996; 27:10-2.
82. Conway JE, Hutchins GM, Tamargo RJ: Marfan syndrome is not associated with intracranial aneurysms. Stroke 1999; 30:1632-6.
83. Conway JE, Hutchins GM, Tamargo RJ: Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: Autopsy study and review of the literature. Stroke 2001; 32:2481-5.
84. Schievink WI, Riedinger M, Maya MM: Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet A 2005; 134:45-8.
85. Norrgard O, Angqvist KA, Fodstad H, Forssell A, Lindberg M: Co-existence of abdominal aortic aneurysms and intracranial aneurysms. Acta Neurochir (Wien) 1987; 87:34-9.
86. Curtis J, Jimenez JA: Intracranial aneurysm with panhypopituitarism with associated aneurysms of thoracic and abdominal aortas. JAMA 1968; 203:982-4.
87. Kim DH, Van Ginhoven G, Milewicz DM: Familial aggregation of both aortic and cerebral aneurysms: Evidence for a common genetic basis in a subset of families. Neurosurgery 2005; 56:655-61; discussion 655-61.
88. Peters DG, Kassam AB, Feingold E et al. Molecular anatomy of an intracranial aneurysm: Coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001; 32:1036-42.
89. Skirgaudas M, Awad IA, Kim J, Rothbart D, Criscuolo G: Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 1996; 39:537-45; discussion 545-37.
90. Roos YB, Pals G, Struycken PM et al. Genome-wide linkage in a large Dutch consanguineous family maps a locus for intracranial aneurysms to chromosome 2p13. Stroke 2004; 35:2276-81.
91. Nahed BV, Seker A, Guclu B et al. Mapping a Mendelian form of intracranial aneurysm to 1p34.3-p36.13. Am J Hum Genet 2005; 76:172-9.
92. Ozturk AK, Nahed BV, Bydon M et al. Molecular genetic analysis of two large kindreds with intracranial aneurysms demonstrates linkage to 11q24-25 and 14q23-31. Stroke 2006; 37:1021-7.
93. Onda H, Kasuya H, Yoneyama T et al. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 2001; 69:804-19.
94. Verlaan DJ, Dube MP, St-Onge J et al. A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3. J Med Genet 2006; 43:e31.
95. Olson JM, Vongpunsawad S, Kuivaniemi H et al. Search for intracranial aneurysm susceptibility gene(s) using Finnish families. BMC Med Genet 2002; 3: 7.
96. van der Voet M, Olson JM, Kuivaniemi H et al. Intracranial aneurysms in Finnish families: Confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 2004; 74:564-71.
97. Farnham JM, Camp NJ, Neuhausen SL et al. Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm. Hum Genet 2004; 114:250-5.
98. Yamada S, Utsunomiya M, Inoue K et al. Absence of linkage of familial intracranial aneurysms to 7q11 in highly aggregated Japanese families. Stroke 2003; 34:892-900.
99. Hofer A, Hermans M, Kubassek N et al. Elastin polymorphism haplotype and intracranial aneurysms are not associated in Central Europe. Stroke 2003; 34:1207-11.
100. Berthelemy-Okazaki N, Zhao Y, Yang Z et al. Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke 2005; 36:1283-4.
101. Yamada S, Utsunomiya M, Inoue K et al. Genome-wide scan for Japanese familial intracranial aneurysms: Linkage to several chromosomal regions. Circulation 2004; 110:3727-33.
102. Coutard M: Experimental cerebral aneurysms in the female heterozygous Blotchy mouse. Int J Exp Pathol 1999; 80:357-67.
103. Gaetani P, Rodriguez y Baena R, Tartara F et al. Metalloproteases and intracranial vascular lesions. Neurol Res 1999; 21:385-90.
104. Juvela S, Siironen J: D-Dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage. Stroke 2006; 37:1451-6.
105. Schisano G, Franco A, Nina P et al. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases. J Neurosurg Sci 1994; 38:77-86.
106. Defawe OD, Colige A, Lambert CA et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Res 2003; 60:205-13.
107. Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M: Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2004; 35:1280-3.
108. Krex D, Rohl H, Konig IR, Ziegler A, Schackert HK, Schackert G: Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 2003; 34:2817-21.
109. Bruno G, Todor R, Lewis I, Chyatte D: Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 1998; 89:431-40.
110. Todor DR, Lewis I, Bruno G, Chyatte D: Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 1998; 29:1580-3.
111. Chyatte D, Lewis I: Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 1997; 28:799-804.
112. Zhao J, Han L, Wang S: In situ localization of mRNA gelatinases in cerebral aneurysms. Zhonghua Yi Xue Za Zhi 1999; 79:822-4.
113. Kim SC, Singh M, Huang J et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997; 41:642-66; discussion 646-7.
114. Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE: Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 1999; 30:2612-6.
115. Caird J, Napoli C, Taggart C, Farrell M, Bouchier-Hayes D: Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J Neurol 2006; 13:1098-105.
116. Pannu H, Kim DH, Guo D et al. The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J Neurosurg 2006; 105:418-23.
117. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H: Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999; 265:563-8.
118. Zhang B, Dhillon S, Geary I et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 2001; 32:2198-202.
119. Krex D, Kotteck K, Konig IR, Ziegler A, Schackert HK, Schackert G: Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in Caucasians with intracranial aneurysms. Neurosurgery 2004; 55: 207-12; discussion 212-203.
120. Kuivaniemi H, Prockop DJ, Wu Y et al. Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: Results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology 1993; 43:2652-8.
121. Majamaa K, Savolainen ER, Myllyla VV: Synthesis of structurally unstable type III procollagen in patients with cerebral artery aneurysm. Biochim Biophys Acta 1992; 1138:191-6.
122. Majamaa K, Myllyla VV: A disorder of collagen biosynthesis in patients with cerebral artery aneurysm. Biochim Biophys Acta 1993; 1225:48-52.
123. Neil-Dwyer G, Bartlett JR, Nicholls AC, Narcisi P, Pope FM: Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg 1983; 59:16-20.
124. de Paepe A, van Landegem W, de Keyser F, de Reuck J: Association of multiple intracranial aneurysms and collagen type III deficiency. Clin Neurol Neurosurg 1988; 90:53-6.
125. van den Berg JS, Limburg M, Pals G et al. Some patients with intracranial aneurysms have a reduced type III/type I collagen ratio. A case-control study. Neurology 1997; 49:1546-51.
126. Kassam AB, Horowitz M, Chang YF, Peters D: Altered arterial homeostasis and cerebral aneurysms: A molecular epidemiology study. Neurosurgery 2004; 54:1450-60; discussion 1460-1452.
127. Yoneyama T, Kasuya H, Onda H et al. Collagen type I alpha2 (COL1A2) is the susceptible gene for intracranial aneurysms. Stroke 2004; 35:443-8.
128. Brega KE, Seltzer WK, Munro LG, Breeze RE: Genotypic variations of type III collagen in patients with cerebral aneurysms. Surg Neurol 1996; 46:253-6; discussion 256-257.
129. Yoneyama T, Kasuya H, Onda H et al. Association of positional and functional candidate genes FGF1, FBN2, and LOX on 5q31 with intracranial aneurysm. J Hum Genet 2003; 48:309-14.
130. Hofer A, Ozkan S, Hermans M et al. Mutations in the lysyl oxidase gene not associated with intracranial aneurysm in central European families. Cerebrovasc Dis 2004; 18:189-93.
131. Krettek A, Sukhova GK, Libby P: Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol 2003; 23:582-7.
132. Miskolczi L, Guterman LR, Flaherty JD, Hopkins LN: Saccular aneurysm induction by elastase digestion of the arterial wall: A new animal model. Neurosurgery 1998; 43:595-600; discussion 600-591.
133. Connolly ES Jr, Fiore AJ, Winfree CJ, Prestigiacoma CJ, Goldman JE, Solomon RA: Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 1997; 40:903-8; discussion 908-909.
134. Marshman LA: Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 1998; 43:982.
135. Stehbens WE: Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 1999; 45:1496-7.
136. Tartara F, Gaetani P, Tancioni F et al. Alpha 1-antitrypsin activity in subarachnoid hemorrhage. Life Sci 1996; 59:15-20.
137. Gaetani P, Tartara F, Tancioni F, Klersy C, Forlino A, Baena RR: Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. J Neurol Sci 1996; 141:33-8.
138. Baker CJ, Fiore A, Connolly ES Jr, Baker KZ, Solomon RA: Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms. Neurosurgery 1995; 37:56-61; discussion 61-52.
139. Gaetani P, Tartara F, Grazioli V, Tancioni F, Infuso L, Rodriguez y Baena R: Collagen cross-linkage, elastolytic and collagenolytic activities in cerebral aneurysms: A preliminary investigation. Life Sci 1998; 63:285-92.
140. Sakai N, Nakayama K, Tanabe Y, Izumiya Y, Nishizawa S, Uemuara K: Absence of plasma protease-antiprotease imbalance in the formation of saccular cerebral aneurysms. Neurosurgery 1999; 45:34-8; discussion 38-39.
141. Slowik A, Borratynska A, Turaj W et al. Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage. Stroke 2005; 36:737-40.
142. Yoneyama T, Kasuya H, Akagawa H et al. Absence of alpha-1 antitrypsin deficiency alleles (S and Z) in Japanese and Korean patients with aneurysmal subarachnoid hemorrhage. Stroke 2004; 35:e376-8.
143. Krischek B, Akagawa H, Tajima A et al. The alanine/threonine polymorphism of the Alpha-1-antichymotrypsin (SERPINA3) gene and ruptured intracranial aneurysms in the Japanese population. Cerebrovasc Dis 2006; 23:46-9.
144. Pera J, Slowik A, Dziedzic T, Szczudlik A: SERPINA3 polymorphism is not associated with primary intracerebral hemorrhage in a Polish population. Stroke 2006; 37:906-7.
145. Yamazoe N, Hashimoto N, Kikuchi H, Hazama F: Elastic skeleton of intracranial cerebral aneurysms in rats. Stroke 1990; 21:1722-6.
146. Ruigrok YM, Seitz U, Wolterink S, Rinkel GJ, Wijmenga C, Urban Z: Association of polymorphisms and haplotypes in the elastin gene in Dutch patients with sporadic aneurysmal subarachnoid hemorrhage. Stroke 2004; 35:2064-8.
147. Krex D, Konig IR, Ziegler A, Schackert HK, Schackert G: Extended single nucleotide polymorphism and haplotype analysis of the elastin gene in Caucasians with intracranial aneurysms provides evidence for racially/ ethnically based differences. Cerebrovasc Dis 2004; 18:104-10.
148. Mineharu Y, Inoue K, Inoue S et al. Association analysis of common variants of ELN, NOS2A, APOE and ACE2 to intracranial aneurysm. Stroke 2006; 37:1189-94.
149. Akagawa H, Tajima A, Sakamoto Y et al. A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms. Hum Mol Genet 2006; 15:1722-34.
150. Frosen J, Piippo A, Paetau A et al. Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: Implications for biological therapy preventing rupture. Neurosurgery 2006; 58:534-41; discussion 534-541.
151. Futami K, Yamashita J, Tachibana O et al. Basic fibroblast growth factor may repair experimental cerebral aneurysms in rats. Stroke 1995; 26:1649-54.
152. Kilic T, Sohrabifar M, Kurtkaya O et al. Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery 2005; 57:997-1007; discussion 1997-1007.
153. Ohkuma H, Suzuki S, Fujita S, Nakamura W: Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation 2003; 108:785-7.
154. Sandalcioglu IE, Wende D, Eggert A, Regel JP, Stolke D, Wiedemayer H: VEGF plasma levels in non-ruptured intracranial aneurysms. Neurosurg Rev 2006; 29:26-9.
155. Gaetani P, Tancioni F, Grignani G et al. Platelet derived growth factor and subarachnoid haemorrhage: A study on cisternal cerebrospinal fluid. Acta Neurochir (Wien) 1997; 139:319-24.
156. Wiesmann M, Missler U, Hagenstrom H, Gottmann D: S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1997; 139:1155-60.
157. Regner A, Kaufman M, Friedman G, Chemale I: Increased serum S100beta protein concentrations following severe head injury in humans: A biochemical marker of brain death? Neuroreport 2001; 12:691-4.
158. Weiss N, Sanchez-Pena P, Roche S et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 2006; 104:658-66.
159. Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N: Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 2006; 37:900-5.
160. Cao Y, Zhao J, Wang S, Zhong H, Wu B: Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36:519-21.
161. Jayaraman T, Berenstein V, Li X et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 2005; 57:558-64; discussion 558-564.
162. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F: Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998; 20:337-42.
163. Hendryk S, Jarzab B, Josko J: Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 2004; 25:141-7.
164. Slowik A, Borratynska A, Turaj W et al. Interleukin 1beta-511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006; 77:279-80.
165. Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE: The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry 2006; 77:915-7.
166. Inoue K, Mineharu Y, Inoue S et al. Search on chromosome 17 centromere reveals TNFRSF13B as a susceptibility gene for intracranial aneurysm: A preliminary study. Circulation 2006; 113:2002-10.
167. Takenaka K, Sakai H, Yamakawa H et al. Polymorphism of the endoglin gene in patients with intracranial saccular aneurysms. J Neurosurg 1999; 90:935-8.
168. Krex D, Ziegler A, Schackert HK, Schackert G: Lack of association between endoglin intron 7 insertion polymorphism and intracranial aneurysms in a white population: Evidence of racial/ethnic differences. Stroke 2001; 32:2689-94.
169. Onda H, Kasuya H, Yoneyama T, Hori T, Nakajima T, Inoue I: Endoglin is not a major susceptibility gene for intracranial aneurysm among Japanese. Stroke 2003; 34:1640-4.
170. Peters DG, Kassam AB, Chang YF: A DNA sequence polymorphism in the endoglin gene is not associated with intracranial aneurysm or aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2005; 20:96-100.
171. Pera J, Slowik A, Dziedzic T et al. Endoglin gene insertion polymorphism not associated with aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102:879-81.
172. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R: Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 1999; 30:1396-401.
173. Mellergard P, Ljunggren B, Brandt L, Johnson U, Holtas S: HLA-typing in a family with six intracranial aneurysms. Br J Neurosurg 1989; 3:479-85.
174. Norrgard O, Beckman G, Beckman L, Cedergren B, Fodstad H, Angquist KA: Genetic markers in patients with intracranial aneurysms. Hum Hered 1987; 37:255-9.
175. Ostergaard JR, Bruun-Petersen G, Lamm LU: HLA antigens and complement types in patients with intracranial saccular aneurysms. Tissue Antigens 1986; 28:176-81.
176. Ryba M, Grieb P, Podobinska I, Iwanska K, Pastuszko M, Gorski A: HLA antigens and intracranial aneurysms. Acta Neurochir (Wien) 1992; 116:1-5.
177. Frijns CJ, Fijnheer R, Algra A, van Mourik JA, van Gijn J, Rinkel GJ: Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: Associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry 2006; 77:77-83.
178. Tanriverdi T, Sanus GZ, Ulu MO et al. Serum and cerebrospinal fluid concentrations of E-selectin in patients with aneurysmal subarachnoid hemorrhage. Braz J Med Biol Res 2005; 38:1703-10.
179. Polin RS, Bavbek M, Shaffrey ME et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998; 89:559-67.
180. Nissen JJ, Mantle D, Gregson B, Mendelow AD: Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: The immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry 2001; 71:329-33.
181. Berendes E, Walter M, Cullen P et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349:245-9.
182. Ikeda K, Ikeda T, Onizuka T, Terashi H, Fukuda T: C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Crit Care 2001; 5:37-40.
183. Slowik A, Borratynska A, Pera J et al. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke 2004; 35:1594-7.
184. Takenaka K, Yamakawa H, Sakai H et al. Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals. Neurol Res 1998; 20:607-11.
185. Keramatipour M, McConnell RS, Kirkpatrick P, Tebbs S, Furlong RA, Rubinsztein DC: The ACE I allele is associated with increased risk for ruptured intracranial aneurysms. J Med Genet 2000; 37:498-500.
186. Pannu H, Kim DH, Seaman CR, Van Ginhoven G, Shete S, Milewicz DM: Lack of an association between the angiotensin-converting enzyme insertion/ deletion polymorphism and intracranial aneurysms in a Caucasian population in the United States. J Neurosurg 2005; 103:92-6.
187. Khurana VG, Meissner I, Meyer FB: Update on genetic evidence for rupture-prone compared with rupture-resistant intracranial saccular aneurysms. Neurosurg Focus 2004; 17:E7.
188. Khurana VG, Meissner I, Sohni YR et al. The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005; 102:526-31.
189. Takenaka KV, Sakai N, Murase S, Kuroda T, Okumura A, Sawada M: Elevated transferrin concentration in cerebral spinal fluid after subarachnoid hemorrhage. Neurol Res 2000; 22:797-801.
190. Khurana VG, Sohni YR, Mangrum WI et al. Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: A putative genetic marker differentiating small versus large ruptured intracranial aneurysms. Stroke 2003; 34:2555-9.
191. Khurana VG, Sohni YR, Mangrum WI et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004; 24:291-7.
192. Akagawa H, Kasuya H, Onda H et al. Influence of endothelial nitric oxide synthase T-786C single nucleotide polymorphism on aneurysm size. J Neurosurg 2005; 102:68-71.
193. Krex D, Fortun S, Kuhlisch E, Schackert HK, Schackert G: The role of endothelial nitric oxide synthase (eNOS) genetic variants in European patients with intracranial aneurysms. J Cereb Blood Flow Metab 2006; 26:1250-5.
194. Fukuda S, Hashimoto N, Naritomi H et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000; 101:2532-8.
195. Sadamasa N, Nozaki K, Hashimoto N: Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 2003; 34:2980-4.
196. Iniesta JA, Corral J, Gonzalez-Conejero R, Piqueras C, Vicente V: Polymorphisms of platelet adhesive receptors: Do they play a role in primary intracerebral hemorrhage? Cerebrovasc Dis 2003; 15:51-5.
197. Iniesta JA, Gonzalez-Conejero R, Piqueras C, Vicente V, Corral J: Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage. Stroke 2004; 35:2282-6.
198. Ruigrok YM, Rinkel GJ, Wijmenga C: The versican gene and the risk of intracranial aneurysms. Stroke 2006; 37:2372-4.
199. Shirakami G, Magaribuchi T, Shingu K et al. Changes of endothelin concentration in cerebrospinal fluid and plasma of patients with aneurysmal subarachnoid hemorrhage. Acta Anaesthesiol Scand 1994; 38:457-61.
200. Gaetani P, Cafe C, Rodriguez y Baena R et al. Superoxide dismutase activity in cisternal cerebrospinal fluid after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1997; 139:1033-7.
201. Gaetani P, Rodriguez y Baena R, Silvani V, Rainoldi F, Paoletti P: Prostacyclin and vasospasm in subarachnoid hemorrhage from ruptured intracranial aneurysm. A preliminary clinical study. Acta Neurol Scand 1986; 73:33-8.
202. Coplin WM, Longstreth WT Jr, Lam AM et al. Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage. Arch Neurol 1999; 56:1348-52.
203. Krex D, Ziegler A, Konig IR, Schackert HK, Schackert G: Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms. Cerebrovasc Dis 2003; 16:363-8.
204. Morgan L, Hawe E, Palmen J, Montgomery H, Humphries SE, Kitchen N: Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms. Br J Neurosurg 2005; 19:317-21.
205. Suzuki Y, Sato S, Suzuki H et al. Increased neuropeptide Y concentrations in cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1989; 20:1680-4.
206. Juul R, Edvinsson L, Fredriksen TA, Ekman R, Brubakk AO, Gisvold SE: Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm. Acta Neurochir (Wien) 1990; 107:75-81.
207. Nonaka N, Matsukado Y, Hirate Y, Mihara Y, Mimata C, Miura G: Lipid metabolism of the patients with subarachnoid hemorrhage due to ruptured intracranial aneurysm - with special reference to the occurrence of cerebral angiospasm. No To Shinkei 1989; 41:67-72.
208. Bolger C, Phillips J, Gilligan S et al. Elevated levels of lipoprotein (a) in association with cerebrovascular saccular aneurysmal disease. Neurosurgery 1995; 37:241-5.
209. Phillips J, Roberts G, Bolger C et al. Lipoprotein (a): A potential biological marker for unruptured intracranial aneurysms. Neurosurgery 1997; 40:1112-5; discussion 1115-1117.
210. Roberts GA, Corcoran BT, Pfouts LL et al. Genetic evaluation of lipoprotein(a) in intracranial aneurysm disease. Neurosurgery 2001; 49:133-40; discussion 141-132.
211. Caird J, Burke M, Roberts G et al. Apolipoprotein(A) expression in intracranial aneurysms. Neurosurgery 2003; 52:854-8; discussion 858-859.
212. Hirashima Y, Endo S, Kurimoto M, Tsukamoto E, Takaku A: Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. Acta Neurochir (Wien) 1994; 128:144-9.
213. Rodriguez y Baena R, Gaetani P, Folco G, Branzoli U, Paoletti P: Cisternal and lumbar CSF concentration of arachidonate metabolites in vasospasm following subarachnoid hemorrhage from ruptured aneurysm: biochemical and clinical considerations. Surg Neurol 1985; 24:428-32.
214. Rodriguez y Baena R, Gaetani P, Paoletti P: A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. J Neurol Sci 1988; 84:329-35.
215. Paoletti P, Gaetani P, Grignani G, Pacchiarini L, Silvani V, Rodriguez y Baena R: CSF leukotriene C4 following subarachnoid hemorrhage. J Neurosurg 1988; 69:488-93.
216. von Holst H, Sollevi A: Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurochir (Wien) 1985; 77:52-9.
217. Zhao YL, Sun YM, Wang S, Zhao JZ, Chen BS: Correlation between APOA gene polymorphism and intracranial aneurysm. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2005; 27:31-4.
218. Tang J, Zhao J, Zhao Y, Wang S, Chen B, Zeng W: Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surg Neurol 2003; 60:391-6; discussion 396-397.
219. Leung CH, Poon WS, Yu LM, Wong GK, Ng HK: Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 2002; 33:548-52.
220. Dunn LT, Stewart E, Murray GD, Nicoll JA, Teasdale GM: The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: A preliminary study. Neurosurgery 2001; 48:1006-10; discussion 1010-1001.
221. Xia J, Yang QD, Yang QM et al. Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population. Cerebrovasc Dis 2004; 17:197-203.
222. Takenaka K, Sakai H, Yamakawa H et al. Analysis of phospholipase C gene in patients with subarachnoid hemorrhage due to ruptured intracranial saccular aneurysm. Neurol Res 1999; 21:368-72.
223. Marchisio M, Sabatino GM, Albanese A, Santavenere E, Buonaguidi R, Miscia S: Novel evidence of PLC delta2 involvement in the regulation of the differential evolution of human aneurysms. Int J Immunopathol Pharmacol 2004; 17:381-8.
224. Sakaki T, Kohmura E, Kishiguchi T, Yuguchi T, Yamashita T, Hayakawa T: Loss and apoptosis of smooth muscle cells in intracranial aneurysms. Studies with in situ DNA end labeling and antibody against single-stranded DNA. Acta Neurochir (Wien) 1997; 139:469-74; discussion 474-465.
225. Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K: Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol (Berlin) 2000; 100:475-80.
226. Takagi Y, Ishikawa M, Nozaki K, Yoshimura S, Hashimoto N: Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms: Role of the c-Jun amino-terminal kinase/c-Jun pathway in apoptosis of vascular walls. Neurosurgery 2002; 51:997-1002; discussion 1002-1004.
227. Pentimalli L, Modesti A, Vignati A et al. Role of apoptosis in intracranial aneurysm rupture. J Neurosurg 2004; 101:1018-25.
228. Kuivaniemi H: Are there genes for aneurysm in the blueprint of the human genome? Ann Vasc Surg 2004; 18:2-3.
229. Kassam A, Horowitz M, Chang YF, Peters D: Altered arterial homeostasis and cerebral aneurysms: A review of the literature and justification for a search of molecular biomarkers. Neurosurgery 2004; 54:1199-212.
230. Khurana VG, Fox DJ, Meissner I, Meyer FB, Spetzler RF: Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus 2006; 21:E3.
231. Eberle MA, Ng PC, Kuhn K et al. Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genet 2007; 3:1827-37.